Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, with sustained improvements in blood pressure, inflammation, liver function, and BMI. Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. Founded in 2014, the company is headquartered in San Francisco, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 8, 2017 | Series A | $37M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
PayPal | — | Series A |
Allen & Company | — | Series A |